NSCLC Coverage From Every Angle
Advertisement
Advertisement

Roy S. Herbst, MD, PhD, on Personalized Immunotherapy for Lung Cancer: Expert Perspective

Posted: Sunday, January 28, 2018

Roy S. Herbst, MD, PhD, of the Yale School of Medicine, discusses finding the most effective combinations, why some tumors are resistant to immunotherapy, and the role of the NCCN guidelines.